Dr. Helen Wheeler trained as a Medical Oncologist in Sydney, Australia. After finishing her medical training, she spent three years in benchtop research in cancer immunology under the supervision of Prof Caroyln Geczy at The Kolling Institute, before taking up a full time position as a staff specialist at Royal North Shore Hospital in Sydney.
Her early oncology career involved management of many different solid tumours but gradually became more focused on primary brain cancer. Although much of her time is spent on clinical work, she has always been involved in clinical trials and translational cancer research.
She is currently Head of Medical Oncology at Royal North Shore and Head of the Medical Oncology clinical trials unit which conducts trials ranging from phase 1 to phase 3 randomised trials as well as clinical translational projects.
She continues to collaborate with the Bill Walsh Cancer laboratory, which has a number of benchtop research projects in brain cancer.
“There is still so much unknown about the cause of brain cancer and treatment remains very limited. Little has changed in the past 20 years. Cure Brain Cancer raises funds that allow this research to continue and gain momentum, giving hope that new treatment will become available in the not too distant future.”